oral semaglutide launch Hims & Hers copies Novo Nordisk's new Wegovy pill Hims and Novo Nordisk: Compounded

Choosing the right format requires looking beyond the basic method of administration

Paying $99 a month for membership while also paying out of pocket for medication felt like a lot

Naast gewichtsverlies werden significante verbeteringen waargenomen in cardiovasculaire risicofactoren: non-HDL-cholesterol, triglyceriden en hsCRP daalden significant

Theyve also been linked, though rarely, with more severe side effects like They also have a notoriously high discontinuation rate: between 50-75% of people who start them stop using them within a year

However, both can affect blood pressure and heart rate, so baseline ECG and regular monitoring are essential

Retatrutide (development name LY3437943) is a synthetic peptide drug developed by Eli Lilly